An observational study in Gynecologic Disease, sponsored by University of Southern California. Recruiting at 1 site in United States. Open to female participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-08-06.
Sponsored by University of Southern California · Observational
This study seeks to understand how endometrial cancer patients get medical information about cancer care and their satisfaction with those health-seeking methods. It also assesses patient interest in using an artificial intelligence educational resource.
AIM 1: Evaluate use of an AI chatbot for HPV vaccine counseling:
PRIMARY OBJECTIVE:
I. To determine patient satisfaction with using an AI chatbot for HPV vaccine counseling.
SECONDARY OBJECTIVE:
I. To understand how patients currently obtain information about cancer care, vaccines, and artificial intelligence.
II. To describe patient experience with the AI-chatbot for vaccine counseling.
AIM 2: Increase rates of HPV vaccine uptake:
PRIMARY OBJECTIVE:
I. To evaluate if implementation of an AI chatbot for HPV vaccine counseling can affect the HPV vaccination rate of new patients served in the gynecologic oncology clinic.
OUTLINE: This is an observational study.
Patients complete a survey on study.
Patients of the LA General gynecologic oncology clinic who meet the eligibility criteria.
AI-chatbot Evaluation (Aim 1):
Inclusion Criteria:
Exclusion Criteria:
HPV vaccination rate (Aim 2):
Inclusion Criteria:
Exclusion Criteria:
Patients complete a survey on study.
Other: Non-Interventional Study
Non-interventional study
Also known as: Non-Interventional Observational Study, Noninterventional (Observational) Study
Patient Satisfaction Scores
Patients will complete a survey to assess their satisfaction with using an AI chatbot for HPV vaccine counseling.
Time frame: Up to 1 year
HPV Vaccination Rate
HPV vaccination rate for patients who received the HPV vaccine counseling with the AI-chatbot
Time frame: Up to 1 year
Demographics of patients
Will be analyzed using a qualitative description of the demographics of patients involved in this specific study.
Time frame: Up to 1 year
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
No contact was published for this record. The registry link below has the sponsor’s details.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University of Southern California